Full Text
Assessing the impact of increased maintenance dosing of Adalimumab and Etanercept on managed care costs

Abstract

Authors

A. Kuznik A. Natu K. Siper M. Auld N. Gilra

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×